# On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men

> **NCT01473472** · PHASE3 · COMPLETED · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 400 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Truvada
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01473472
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2016-06-30
- **Final completion:** 2016-12-15
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2017-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01473472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01473472, "On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01473472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*